Amedisys (AMED)
(Delayed Data from NSDQ)
$97.75 USD
+0.17 (0.17%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $97.84 +0.09 (0.09%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth B Momentum C VGM
Earnings News For AMED
-
Amedisys (AMED) Q2 Earnings and Revenues Top Estimates
-
Amedisys: Q2 Earnings Snapshot
-
Amedisys Reports Second Quarter 2024 Financial Results
-
Why Is Amedisys (AMED) Up 5.5% Since Last Earnings Report?
-
Amedisys (AMED) Q1 Earnings Surpass Estimates, Margins Rise
-
Amedisys (AMED) Q1 Earnings and Revenues Surpass Estimates
-
Amedisys: Q1 Earnings Snapshot
-
Amedisys Reports First Quarter 2024 Financial Results
-
Amedisys (AMED) Earnings Expected to Grow: What to Know Ahead of Q1 Release
-
Why Is Amedisys (AMED) Down 2.5% Since Last Earnings Report?
-
Amedisys' (AMED) Q4 Earnings Miss Estimates, Margins Up
-
Amedisys: Q4 Earnings Snapshot
-
Amedisys (AMED) Q4 Earnings Lag Estimates
-
Amedisys Reports Fourth Quarter and Year-End 2023 Financial Results
-
Amedisys (AMED) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
-
Amedisys (AMED) Up 2.6% Since Last Earnings Report: Can It Continue?
-
Amedisys' (AMED) Q3 Earnings Miss Estimates, Margins Up
-
Amedisys (AMED) Q3 Earnings and Revenues Lag Estimates
-
Amedisys: Q3 Earnings Snapshot
-
Amedisys Reports Third Quarter 2023 Financial Results
-
Amedisys (AMED) Q2 Earnings Beat Estimates, Margins Dip
-
Amedisys (AMED) Tops Q2 Earnings Estimates
-
Amedisys: Q2 Earnings Snapshot
-
Amedisys Reports Second Quarter 2023 Financial Results
-
Earnings Preview: Amedisys (AMED) Q2 Earnings Expected to Decline